CAD 0.04
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 61.93 Thousand CAD | -55.17% |
2022 | 138.15 Thousand CAD | -38.58% |
2021 | 224.94 Thousand CAD | -70.01% |
2020 | 750.01 Thousand CAD | 148.03% |
2019 | 302.38 Thousand CAD | 213.65% |
2018 | 96.4 Thousand CAD | 668.5% |
2017 | 12.54 Thousand CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 42.22 Thousand CAD | 4.47% |
2024 Q1 | 40.42 Thousand CAD | 172.73% |
2023 Q4 | 14.82 Thousand CAD | 237.99% |
2023 Q2 | 2037.00 CAD | -94.99% |
2023 FY | 61.93 Thousand CAD | -55.17% |
2023 Q1 | 40.69 Thousand CAD | 14.37% |
2023 Q3 | 4385.00 CAD | 115.27% |
2022 Q2 | 29.52 Thousand CAD | -23.43% |
2022 Q4 | 35.57 Thousand CAD | 3.12% |
2022 FY | 138.15 Thousand CAD | -38.58% |
2022 Q1 | 38.55 Thousand CAD | -4.24% |
2022 Q3 | 34.5 Thousand CAD | 16.88% |
2021 FY | 224.94 Thousand CAD | -70.01% |
2021 Q2 | 76.3 Thousand CAD | 3.82% |
2021 Q4 | 40.25 Thousand CAD | 15.37% |
2021 Q3 | 34.89 Thousand CAD | -54.27% |
2021 Q1 | 73.49 Thousand CAD | -46.3% |
2020 Q4 | 136.85 Thousand CAD | -24.39% |
2020 Q3 | 180.99 Thousand CAD | 79.78% |
2020 Q2 | 100.67 Thousand CAD | -65.46% |
2020 FY | 750.01 Thousand CAD | 148.03% |
2020 Q1 | 291.48 Thousand CAD | 168.39% |
2019 Q2 | 55.7 Thousand CAD | -5.86% |
2019 Q1 | 59.16 Thousand CAD | 19.52% |
2019 FY | 302.38 Thousand CAD | 213.65% |
2019 Q4 | 108.6 Thousand CAD | 37.64% |
2019 Q3 | 78.9 Thousand CAD | 41.66% |
2018 Q2 | 17.97 Thousand CAD | 0.0% |
2018 Q3 | 28.92 Thousand CAD | 60.88% |
2018 FY | 96.4 Thousand CAD | 668.5% |
2018 Q4 | 49.5 Thousand CAD | 71.16% |
2018 Q1 | - CAD | -100.0% |
2017 Q4 | 12.54 Thousand CAD | 0.0% |
2017 FY | 12.54 Thousand CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aion Therapeutic Inc. | 367.47 Thousand CAD | 83.146% |
Ayurcann Holdings Corp. | 25.15 Million CAD | 99.754% |
Blueberries Medical Corp. | 288.27 Thousand CAD | 78.515% |
The BC Bud Corporation | 61.48 Thousand CAD | -0.735% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | 83.362% |
CordovaCann Corp. | 13.59 Million CAD | 99.544% |
Christina Lake Cannabis Corp. | 11.77 Million CAD | 99.474% |
Captor Capital Corp. | 36.76 Million CAD | 99.832% |
City View Green Holdings Inc. | 8582.00 CAD | -621.673% |
1CM Inc. | 35.34 Million CAD | 99.825% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | 98.816% |
IM Cannabis Corp. | 48.8 Million CAD | 99.873% |
Lobe Sciences Ltd. | 840.53 Thousand CAD | 92.632% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -3.223% |
Nextleaf Solutions Ltd. | 8.17 Million CAD | 99.243% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | 174.78 Thousand CAD | 64.566% |
RAMM Pharma Corp. | 5.06 Million CAD | 98.777% |
RIV Capital Inc. | 7.48 Million CAD | 99.173% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 88.33 Million CAD | 99.93% |
SLANG Worldwide Inc. | 35.68 Million CAD | 99.826% |
1933 Industries Inc. | 18.27 Million CAD | 99.661% |
Red Light Holland Corp. | 4.75 Million CAD | 98.697% |
Top Strike Resources Corp. | 13.32 Million CAD | 99.535% |
Xebra Brands Ltd. | 106.85 Thousand CAD | 42.039% |
Adastra Holdings Ltd. | 22.22 Million CAD | 99.721% |